Immunogenicity and safety of co-administration of AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine and a COVID-19 mRNA vaccine in adults aged >/=50 years: a phase 3, randomized, non-inferiority trial. (academic.oup.com)

Authors: Bonten M … Van der Wielen M Journal: Clinical Infectious Diseases Published: 2026-06-04 DOI: https://doi.org/10.1093/cid/ciag344